Literature DB >> 3533987

Rapid double-sandwich enzyme-linked immunosorbent assay for detection of human immunoglobulin M anti-Toxoplasma gondii antibodies.

J P Tomasi, A F Schlit, S Stadtsbaeder.   

Abstract

The double-sandwich enzyme-linked immunosorbent assay has been compared with the indirect fluorescence assay for the detection of immunoglobulin M antibodies against Toxoplasma gondii in humans. Incubation times have been shortened, permitting the test to be completed within 2 h. The double-sandwich enzyme-linked immunosorbent assay is confirmed to be more sensitive and more specific than the immunofluorescence assay.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533987      PMCID: PMC269041          DOI: 10.1128/jcm.24.5.849-850.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Respective role of antibodies and immune macrophages during acquired immunity against toxoplasmosis in mice.

Authors:  S Stadtsbaeder; B T Nguyen; M C Calvin-Preval
Journal:  Ann Immunol (Paris)       Date:  1975 Jun-Jul

2.  Serodiagnosis of human G and M immunoglobulins to Toxoplasma gondii by ELISA using whole tachyzoites as antigens: a comparative study with the indirect haemagglutination (IHA) and immunofluorescence (IFA) tests.

Authors:  J P Tomasi; N Barka; S Stadtsbaeder
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

3.  Specific detection of IgM-antibodies by ELISA, applied in hepatitis-A.

Authors:  W Duermeyer; J van der Veen
Journal:  Lancet       Date:  1978-09-23       Impact factor: 79.321

4.  A comparative study of horseradish peroxidase conjugates prepared with a one-step and a two-step method.

Authors:  D M Boorsma; G L Kalsbeek
Journal:  J Histochem Cytochem       Date:  1975-03       Impact factor: 2.479

5.  Comparison of methods for quantitating antigen-specific immunoglobulin M antibody with a reverse enzyme-linked immunosorbent assay.

Authors:  J P Siegel; J S Remington
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

6.  IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital Toxoplasma infection.

Authors:  Y Naot; G Desmonts; J S Remington
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

7.  Diagnosis of acute toxoplasmosis by an enzyme immunoassay for specific immunoglobulin m antibodies.

Authors:  F Wielaard; H van Gruijthuijsen; W Duermeyer; A W Joss; L Skinner; H Williams; E H van Elven
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

8.  Enzyme-linked immunosorbent assay (ELISA) using antibody class capture for the detection of antitoxoplasma IgM.

Authors:  R A Payne; M Isaac; J M Francis
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

9.  An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis.

Authors:  Y Naot; J S Remington
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

  9 in total
  4 in total

1.  Comparison of six commercial enzyme linked immunosorbent assays for detecting IgM antibodies against Toxoplasma gondii.

Authors:  C Verhofstede; L Van Renterghem; J Plum
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

2.  Unspecific reactivity of IgM directed against the low-molecular-weight antigen of Toxoplasma gondii.

Authors:  A Dao; N Azzouz; C Eloundou Nga; J F Dubremetz; R T Schwarz; B Fortier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-24       Impact factor: 3.267

Review 3.  Diagnosis of toxoplasmosis and typing of Toxoplasma gondii.

Authors:  Quan Liu; Ze-Dong Wang; Si-Yang Huang; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2015-05-28       Impact factor: 3.876

Review 4.  Review on the Current Trends of Toxoplasmosis Serodiagnosis in Humans.

Authors:  Rochelle Haidee D Ybañez; Adrian P Ybañez; Yoshifumi Nishikawa
Journal:  Front Cell Infect Microbiol       Date:  2020-05-08       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.